FGF2, an Immunomodulatory Factor in Asthma and Chronic Obstructive Pulmonary Disease (COPD).
10.3389/fcell.2020.00223
Saved in:
Main Authors: | Tan, Yuanyang, Qiao, Yongkang, Chen, Zhuanggui, Liu, Jing, Guo, Yanrong, Tran, Thai, Tan, Kai Sen, Wang, De-Yun, Yan, Yan |
---|---|
Other Authors: | PHYSIOLOGY |
Format: | Review |
Published: |
Frontiers Media SA
2020
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/167246 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Microbiomes in respiratory health and disease: An Asia-Pacific perspective
by: Chotirmall, Sanjay Haresh, et al.
Published: (2017) -
Treatment of severe exacerbation of chronic obstructive pulmonary disease with mask-applied continuous positive airway pressure
by: Lim, T.K.
Published: (2016) -
Understanding COPD-overlap syndromes
by: Poh, Tuang Yeow, et al.
Published: (2017) -
Vapor, dust, and smoke exposure in relation to adult-onset asthma and chronic respiratory symptoms: The Singapore Chinese Health Study
by: LeVan, T.D., et al.
Published: (2014) -
Economic and clinical outcomes of easy asthma and chronic obstructive pulmonary disease at Wangtong Hospital, Phitsanulok
by: N. Chalermpanchai, et al.
Published: (2012)